August 23, 2013
The Central Social Insurance Medical Council (CSIMC), an advisory body to the health minister, gave approval on August 21 for Shionogi’s Irtra Combination Tablets LD and HD containing angiotensin receptor blocker (ARB) Irbetan (irbesartan) and diuretic Fluitran (trichlormethiazide) to be...read more